Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for uniQure
Company Monitoring Page for uniQure
latest headlines for company on cafepharma
Benefit of uniQure's Huntington's gene therapy will be revealed 'in the fullness of time'
Fierce Biotech
Tue, 12/19/23 - 11:14 pm
Tags:
uniQure
,
Huntington's disease
,
gene therapy
Gene therapy maker UniQure to cut about 20% of workforce
Reuters
Thu, 10/5/23 - 10:10 am
Tags:
uniQure
,
gene therapy
,
layoffs
Uniqure’s accelerated approval hopes take a hit
EP Vantage
Thu, 06/22/23 - 10:07 am
Tags:
uniQure
,
Huntington's disease
,
gene therapy
,
AMT-130
After Hemgenix approvals, uniQure cashes out some of its royalty rights for $375M-plus
Fierce Pharma
Mon, 05/15/23 - 06:23 pm
Tags:
uniQure
,
Hemgenix
,
gene therapy
,
hemophilia A
Major readouts on the horizon for small developers
EP Vantage
Fri, 03/31/23 - 10:19 am
Tags:
Aldeyra Therapeutics
,
Autolus Therapeutics
,
Bavarian Nordic
,
BioXcel Therapeutics
,
Disc Medicine
,
Editas Medicine
,
Immunogen
,
Lantheus
,
Mersana Therapeutics
,
NGM Biopharmaceuticals
,
Omeros
,
Roche
,
Sutro BioPharma
,
uniQure
,
Valneva
,
Viking Therapeutics
10 clinical trials to watch in the first half of 2023
BioPharma Dive
Tue, 01/3/23 - 10:57 am
Tags:
clinical trials
,
Alzheimer's disease
,
obesity
,
Huntington's disease
,
M&A
,
AstraZeneca
,
Daiichi Sankyo
,
Nimbus Therapeutics
,
Takeda
,
Eli Lilly
,
Sanofi
,
Regeneron
,
Moderna Therapeutics
,
Gilead Sciences
,
Pfizer
,
Roivant
,
Alnylam
,
uniQure
Big pharma’s new year catalysts
EP Vantage
Mon, 12/19/22 - 11:05 am
Tags:
AstraZeneca
,
Daiichi Sankyo
,
Pfizer
,
Roche
,
CSL
,
uniQure
,
Novo Nordisk
,
Eli Lilly
Bristol Myers has change of heart on cardiovascular gene therapy pact, terminating uniQure deal
Fierce Biotech
Tue, 11/29/22 - 10:57 am
Tags:
Bristol Myers Squibb
,
uniQure
,
gene therapy
uniQure, CSL claim first okay for hemophilia B gene therapy
Pharmaphorum
Wed, 11/23/22 - 07:53 am
Tags:
uniQure
,
CSL
,
hemophila B
,
gene therapy
,
Hemgenix
,
FDA
UniQure revs up engines again for Huntington's gene therapy after trial hospitalizations
Fierce Biotech
Wed, 11/2/22 - 10:49 pm
Tags:
uniQure
,
Huntington's disease
,
gene therapy
,
AMT-130
uniQure pauses part of Huntington's trial after 3 patients hospitalized—1 of whom hasn’t fully recovered
Fierce Biotech
Mon, 08/8/22 - 11:33 pm
Tags:
uniQure
,
clinical trials
,
Huntington's disease
,
AMT-130
uniQure shares spike as investors see bright spot in 12-month Huntington's gene therapy data
Fierce Biotech
Thu, 06/23/22 - 07:51 pm
Tags:
uniQure
,
Huntington's disease
,
gene therapy
,
AMT-130
CSL-UniQure Hemophilia B Gene Therapy Scores Priority Review
BioSpace
Tue, 05/24/22 - 04:34 pm
Tags:
CSL Behring
,
uniQure
,
hemophilia B
,
gene therapy
,
FDA
,
priority review
,
etranacogene dezaparvovec
As biotech retreats, gene therapy companies retrench and redraw plans
BioPharma Dive
Thu, 03/24/22 - 08:29 pm
Tags:
biotech
,
gene therapy
,
layoffs
,
R&D
,
Bluebird Bio
,
Allogene
,
uniQure
Fresh data show UniQure's hemophilia gene therapy appears to hold up
BioPharma Dive
Fri, 12/10/21 - 12:01 am
Tags:
uniQure
,
gene therapy
,
hemophilia
,
hemophilia B
Biotech M&A tracker: After hitting new heights, deals have slowed down. Here are the latest.
BioPharma Dive
Tue, 08/10/21 - 11:12 pm
Tags:
M&A
,
Bayer
,
Sanofi
,
Amgen
,
uniQure
,
MorphoSys
,
Xeris Pharmaceuticals
,
Relay Therapeutics
,
Merck
,
Beam Therapeutics
,
Jazz Pharmaceuticals
Gene therapy for Fabry: early stages, promising results
BioPharma Dive
Thu, 07/22/21 - 10:02 pm
Tags:
gene therapy
,
Fabry disease
,
uniQure
,
Avrbio
,
Freeline Therapeutics
,
Sangamo Therapeutics
Late-Stage Clinical Study Readouts Biotech Investors Should Watch
Motley Fool
Sun, 07/11/21 - 11:13 pm
Tags:
clinical trials
,
Novartis
,
Biogen
,
SAGE Therapeutics
,
uniQure
,
Pfizer
,
Roche
Biopharma takeovers dry up
EP Vantage
Mon, 07/5/21 - 09:50 pm
Tags:
M&A
,
MorphoSys
,
Constellation Pharmaceuticals
,
Sanofi
,
Tidal Therapeutics
,
uniQure
,
Corlieve Therapeutics
,
Strongbridge Biopharma
,
Xerix Pharmaceuticals
,
Novellus Therapeutics
,
Brooklyn Immunotherapeutics
With FDA filing for key gene therapy pushed back 6 months, uniQure opens the pocketbook to refresh the pipeline
Endpoints
Tue, 06/22/21 - 10:37 pm
Tags:
uniQure
,
M&A
,
Corlieve Therapeutics
,
AMT-260
,
gene therapy
,
temporal lobe epilepsy
Pages
1
2
3
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.